chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. On 05-DEC-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # K019386, expiration date 09-JUN-2016). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 48 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. this is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager via two company representatives referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 05-JUL-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml (lot # L010598, expiration date 06-AUG-2016, route unknown). The total cumulative excursion time was 24 hours with the highest recorded temperature of 47 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and practice manager referring to a patient of unknown age and gender. On 02-OCT-2014 the patient was vaccinated with an improperly stored PNEUMOVAX 23 (strength: 0.5ml, lot # K004281, expire date 22-MAR-2015; dose and route of unknown). The total cumulative excursion time was 1368 hours with the lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. On 04-DEC-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # K019386, expiration date 09-JUN-2016). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 48 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for the vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician via company employees and a practice manager referring to a patient of unknown age and gender. On 03-MAY-2016 the patient was vaccinated with an improperly stored dose of (wistar ra 27-3) M-M-R II (rHA (recombinant human albumin), lot #L003856, expiration date 05-FEB-2017, strength, dose and route were unspecified). This specified lot number vaccine was exposed to temperature twice. The total cumulative excursion time of the first time was 904 hours with the lowest recorded temperature of 34 Fahrenheit degree. The total cumulative excursion time of the second time was 168 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria of this vaccine was refrigerator/freezer (R/F) and the type of excursion was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 30-JAN-2015 the patient was vaccinated with an improperly stored dose of M-M-R II single 0.5 ml (HSA, lot # J006136, expiration date 22-OCT-2016, dose and route unknown). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 456 hours with the highest recorded temperature of 6 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was freezer (F). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 24-JUN-2016 the patient was vaccinated with an improperly stored dose of GARDASIL single-dose vial (SDV) lot # L035105 expiration date 14-MAY-2017, dose and route were unspecified. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of 8.7 Fahrenheit degree (also reported as Celsius degree). The total cumulative excursion time of the second time was 24 hours with the lowest recorded temperature of 9 Fahrenheit degree (also reported as Celsius degree). The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager via two company representatives referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 19-JUL-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml (lot # L010598, expiration date 06-AUG-2016, route unknown). The total cumulative excursion time was 24 hours with the highest recorded temperature of 47 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager via two company representatives referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 11-JUL-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml (lot # L010598, expiration date 06-AUG-2016, route unknown). The total cumulative excursion time was 24 hours with the highest recorded temperature of 47 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 21-JUL-2016 the patient was vaccinated with an improperly stored dose of (Wistar RA 27-3) M-M-R II 0.5 ml (lot #L003856, expiration date 02-FEB-2017,  therapy type recombinant human albumin (rHA), dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion eight times. The total cumulative excursion time of the first time was 204 hours with the lowest recorded temperature of 33 Fahrenheit degree; the second time was 444 hours with the lowest recorded temperature of 34 Fahrenheit degree; the third time was 24 hours with the highest recorded temperature of 49 Fahrenheit degree; the fourth time was 24 hours with the lowest recorded temperature of 21.7 Fahrenheit degree; the fifth time was 1192 hours with the lowest recorded temperature of 29 Fahrenheit degree; the sixth time was 24 hours with the lowest recorded temperature of 31 Fahrenheit degree; the seventh time was 96 hours with the highest recorded temperature of 48 Fahrenheit degree; the eighth time was 304 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria and the type of excursion for this type of excursion for this vaccine were refrigerator (R)/ freezer (F). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 22-JUN-2016 the patient was vaccinated with an improperly stored dose M-M-R II 0.5 ml (lot # L003856, expiration date 02-FEB-2017, therapy type recombinant human albumin (rHA), dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion eight times. The total cumulative excursion time of the first time was 204 hours with the lowest recorded temperature of 33 Fahrenheit degree; the second time was 444 hours with the lowest recorded temperature of 34 Fahrenheit degree; the third time was 24 hours with the highest recorded temperature of 49 Fahrenheit degree; the fourth time was 24 hours with the lowest recorded temperature of 21.7 Fahrenheit degree; the fifth time was 1732 hours with the lowest recorded temperature of 29 Fahrenheit degree; the sixth time was 24 hours with the lowest recorded temperature of 31 Fahrenheit degree; the seventh time was 96 hours with the highest recorded temperature of 48 Fahrenheit degree; the eighth time was 304 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine were refrigerator (R)/freezer (F). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 05-JUL-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion two times. The total cumulative excursion time of the first time was 144 hours with the lowest recorded temperature of 32 Fahrenheit degree. The total cumulative excursion time of the second time was 144 hours with the lowest recorded temperature of 24 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 11-JUL-2016 the patient was vaccinated with an improperly stored dose of GARDASIL single-dose vial (SDV) lot # L035105 expiration date 14-MAY-2017, dose and route were unspecified. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of 9 Fahrenheit degree (also reported as Celsius degree). The total cumulative excursion time of the second time was 24 hours with the lowest recorded temperature of 8.7 Fahrenheit degree (also reported as Celsius degree). The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 07-OCT-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K004281, expire date 22-MAR-2015; dose and route unknown). The total cumulative excursion time was 1488 hours with the lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 18-JUL-2016 the patient was vaccinated with an improperly stored dose of M-M-R II 0.5 ml (lot # L003856, expiration date 02-FEB-2017, therapy type recombinant human albumin (rHA), dose and route were unspecified). This specified lot number vaccine was exposed to temperature  excursion eight time. The total cumulative excursion time of the first time was 204 hours with the lowest recorded temperature of 33 Fahrenheit degree; the second time was 444 hours with the lowest recorded temperature of 34 Fahrenheit degree; the third time was 24 hours with the highest recorded temperature of 49 Fahrenheit degree; the fourth time was 24 hours with the lowest recorded temperature of 21.7 Fahrenheit degree; the fifth time was 1732 hours with the lowest recorded temperature of 29 Fahrenheit degree; the sixth time was 24 hours with the lowest recorded temperature of 31 Fahrenheit degree; the seventh time was 96 hours with the highest recorded temperature of 48 Fahrenheit degree; the eighth time was 304 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine were refrigerator (R)/ freezer (F). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 26-AUG-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of -1 Fahrenheit degree. The total cumulative excursion time of the second time was 48 hours with the lowest recorded temperature of 0 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 20-JUN-2016 the patient was vaccinated with an improperly stored dose of GARDASIL single-dose vial (SDV) lot # L035105 expiration date 14-MAY-2017, dose and route were unspecified. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of 8.7 Fahrenheit degree (also reported as Celsius degree). The total cumulative excursion time of the second time was 24 hours with the lowest recorded temperature of 9 Fahrenheit degree (also reported as Celsius degree). The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 16-JUN-2016 the patient was vaccinated with an improperly stored dose of M-M-R II 0.5 ml (lot # L003856, expiration date 02-FEB-2017, therapy type recombinant human albumin (rHA), dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion eight times. The total cumulative excursion time of the first time was 204 hours with the lowest recorded temperature of 33 Fahrenheit degree; the second time was 444 hours with the lowest recorded temperature of 34 Fahrenheit degree; the third time was 24 hours with the highest recorded temperature of 49 Fahrenheit degree; the fourth time was 24 hours with the lowest recorded temperature of 21.7 Fahrenheit degree; the fifth time was 1732 hours with the lowest recorded temperature of 29 Fahrenheit degree; the sixth time was 24 hours with the lowest recorded temperature of 31 Fahrenheit degree; the seventh time was 96 hours with the highest recorded temperature of 48 Fahrenheit degree; the eighth time was 304 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine were refrigerator (R)/freezer (F). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 23-JAN-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of -1 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 23-SEP-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5 ml, lot # K004281, expire date 22-MAR-2015; dose and route unknown). The total cumulative excursion time was 1152 hours with the lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 08-APR-2016 the patient was vaccinated with an improperly stored dose of (Wistar RA 27-3) M-M-R II 0.5 ml (lot #L003856, expiration date 02-FEB-2017, therapy type recombinant human albumin (rHA), dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion eight times. The total cumulative excursion time of the first time was 204 hours with the lowest recorded temperature of 33 Fahrenheit degree; the second time was 444 hours with the lowest recorded temperature of 34 Fahrenheit degree; the third time was 24 hours with the highest recorded temperature of 49 Fahrenheit degree; the fourth time was 24 hours with the lowest recorded temperature of 21.7 Fahrenheit degree; the fifth time was 1192 hours with the lowest recorded temperature of 29 Fahrenheit degree; the sixth time was 24 hours with the lowest recorded temperature of 31 Fahrenheit degree; the seventh time was 96 hours with the highest recorded temperature of 48 Fahrenheit degree; the eighth time was 304 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria and the type of excursion for this type of excursion for this vaccine were refrigerator (R)/ freezer (F). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 22-SEP-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K004281, expire date 22-MAR-2015; dose and route unknown). The total cumulative excursion time was 1128 hours with the lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 18-JUL-2016 the patient was vaccinated with an improperly stored dose of GARDASIL single-dose vial (SDV) lot # L035105 expiration date 14-MAY-2017, dose and route were unspecified. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of 8.7 Fahrenheit degree (also reported as Celsius degree). The total cumulative excursion time of the second time was 24 hours with the lowest recorded temperature of 9 Fahrenheit degree (also reported as Celsius degree). The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist referring a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On 11-OCT-2016 the patient was inadvertently vaccinated with an expired dose of ZOSTAVAX 19400 PFU with lot number H013020, expiration date 09-OCT-2013, 0.65 ml, subcutaneously. No adverse events were reported. There was no product quality complaint involved. Additional information has been requested.
Sex: M
Vaccine: PPV
Symptoms: Pyrexia, Tenderness
Clinical narrative: This spontaneous report as received from a consumer via company representative regarding a male patient in his 70's (years old). The patient's medical history, concurrent condition and concomitant medications were not reported. On an unknown date in 2015, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dosing details and lot# unknown). Other suspect therapies included PREVNAR 13 (dosing details unknown). On an unknown date in 2015 reported as following the administration of the shot, the patient experienced fever and tenderness. The outcome of fever and tenderness was unknown. Causality assessment was not reported. This case was cross referenced with LRN W2016256280. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a physician via two company representatives from a practice manager (support services director) and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 04-SEP-2014, the patient was vaccinated with an improperly stored dose of GARDASIL 5 mg/0.5 ml injection, lot # J014219, expiration date 05-OCT-2015 (dose, route and site of administration were not reported). The administered dose of vaccine was exposed to two temperature excursions (dates unspecified) lasting for 168 hours, with the lowest recorded temperature of 34 degrees Fahrenheit (1.111111111 degrees Celsius) and the another lasting for 24 hours, with the lowest recorded temperature of 33 degrees Fahrenheit (0.555555556 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 07-OCT-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (STRENGTH: 0.5ml, lot # K004281, expire date 22-MAR-2015; dose and route unknown). The total cumulative excursion time was 1488 hours with the lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 75.0
Sex: F
Vaccine: FLUX, PPV, FLU3, PPV, FLUX, PPV, FLU4, PPV, FLU4, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV
Symptoms: Injected limb mobility decreased, Injection site reaction, Myalgia
Clinical narrative: Extreme soreness for the arm that they got the PNEUMOVAX shot in. Patient treated with over the counter pain meds.
Age: 75.0
Sex: F
Vaccine: FLUX, PPV, FLU3, PPV, FLUX, PPV, FLU4, PPV, FLU4, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV
Symptoms: Pain in extremity
Clinical narrative: Extreme soreness for the arm that they got the PNEUMOVAX shot in. Patient treated with over the counter pain meds.
Age: 75.0
Sex: F
Vaccine: FLUX, PPV, FLU3, PPV, FLUX, PPV, FLU4, PPV, FLU4, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV
Symptoms: Injected limb mobility decreased, Myalgia
Clinical narrative: Extreme soreness for the arm that they got the PNEUMOVAX shot in. Patient treated with over the counter pain meds.
Age: 75.0
Sex: F
Vaccine: FLUX, PPV, FLU3, PPV, FLUX, PPV, FLU4, PPV, FLU4, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV
Symptoms: Fall, Mobility decreased, Pain, Pain in extremity
Clinical narrative: Extreme soreness for the arm that they got the PNEUMOVAX shot in. Patient treated with over the counter pain meds.
Age: 75.0
Sex: F
Vaccine: FLUX, PPV, FLU3, PPV, FLUX, PPV, FLU4, PPV, FLU4, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV
Symptoms: Fall, Injected limb mobility decreased, Pain in extremity
Clinical narrative: Extreme soreness for the arm that they got the PNEUMOVAX shot in. Patient treated with over the counter pain meds.
Age: 75.0
Sex: F
Vaccine: FLUX, PPV, FLU3, PPV, FLUX, PPV, FLU4, PPV, FLU4, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV
Symptoms: Mobility decreased, Myalgia
Clinical narrative: Extreme soreness for the arm that they got the PNEUMOVAX shot in. Patient treated with over the counter pain meds.
Age: 75.0
Sex: F
Vaccine: FLUX, PPV, FLU3, PPV, FLUX, PPV, FLU4, PPV, FLU4, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV, FLUX, PPV
Symptoms: Disability, Mobility decreased
Clinical narrative: Extreme soreness for the arm that they got the PNEUMOVAX shot in. Patient treated with over the counter pain meds.
Age: 59.0
Sex: M
Vaccine: FLU4, FLUR3
Symptoms: Pain, Pain in extremity
Clinical narrative: Sore shoulder. Pain with movement, lifting arm above head difficulty and pain. Pain if sleeping on left arm.
Age: 59.0
Sex: M
Vaccine: FLU4, FLUR3
Symptoms: Mobility decreased, Musculoskeletal pain, Pain, Pain in extremity, Sleep disorder
Clinical narrative: Sore shoulder. Pain with movement, lifting arm above head difficulty and pain. Pain if sleeping on left arm.
Age: 36.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Asthenia, Dyspnoea, Feeling hot, Nausea, Pallor
Clinical narrative: Shortness of breath, Redman syndrom like redness all over body and face. Inject Epipen.
Age: 36.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Tremor
Clinical narrative: Shortness of breath, Redman syndrom like redness all over body and face. Inject Epipen.
Age: 36.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Dyspnoea, Erythema
Clinical narrative: Shortness of breath, Redman syndrom like redness all over body and face. Inject Epipen.
Age: 72.0
Sex: M
Vaccine: PPV
Symptoms: Injection site pruritus, Injection site rash, Rash
Clinical narrative: Light rash on face, neck and back. Itching at site of rash, orthopnea. Treated with Benadryl, 25 mg and Advair, 250/50 mcg.
Age: 1.08
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash, Rash generalised, Vomiting
Clinical narrative: Fever started Wednesday pm, continued until Saturday AM, vomiting Friday and rash started behind her ears Friday, rash was all over by Saturday.
Age: 31.0
Sex: M
Vaccine: FLU3
Symptoms: Thirst, Throat tightness
Clinical narrative: Patient reported getting very thirsty and then felt as though his throat was closing.
Age: 26.0
Sex: M
Vaccine: FLU4
Symptoms: Pyrexia, Urticaria
Clinical narrative: Patient presented to clinic on 10/16/2016 stating he had broken out in hives/felt "feverish" 12 hours after the vaccination. Denied trouble swallowing or shortness of breath. States he didn't try calling the clinic or didn't seek emergency care. Took Benadryl with some relief.
Age: 63.0
Sex: F
Vaccine: FLUX
Symptoms: Diarrhoea, Headache, Myalgia, Nausea, Vomiting
Clinical narrative: Nausea, vomiting, diarrhea, severe muscle aches and headache.
Age: 39.0
Sex: F
Vaccine: FLU4
Symptoms: Burning sensation, Skin warm, Urticaria
Clinical narrative: It felt like fire on the inside of my arm as soon as the medicine was injected. It was hot to the touch within minutes of me getting the injection and I immediately broke out in hives. I reported it to office manager and took puctures. my treatment was me taking Benedryl.
Age: 65.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event reported by the patient. He got the same Vaccine (PREVNAR 13) twice. Once on 12/18/2015 at the doctor's office (at age 64 years and 7 months) and the second time on 9/15/2016. Patient had another MCIR file. Hence could not identify that he had already gotten the vaccination. However, Patient doesn't think he got the vaccine in December.
Age: 21.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness
Clinical narrative: Patient became dizzy after walking away and we had to sit pt down until feeling better.
Age: 75.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Erythema, Musculoskeletal stiffness, Neck pain, Tenderness
Clinical narrative: Severe neck stiffness and pain.Arm tenderness and redness.
Age: 0.42
Sex: F
Vaccine: PNC13
Symptoms: Administration site swelling, Crying, Irritability, Pyrexia
Clinical narrative: SWELLING OF THE VACCINE ADMINISTRATION SITE, FEVER, FUSSINESS, DROWSINESS, IRRITABILITY, INCONSOLABLE CRYING.
Age: 80.0
Sex: M
Vaccine: FLU3, PPV, FLU4, PPV, FLU4
Symptoms: Injection site pain
Clinical narrative: Patient had extreme soreness in the arm where the Pneumovax was given. Patient treated it with OTC pain meds.
Age: 80.0
Sex: M
Vaccine: FLU3, PPV, FLU4, PPV, FLU4
Symptoms: Injected limb mobility decreased, Injection site pain, Pain in extremity
Clinical narrative: Patient had extreme soreness in the arm where the Pneumovax was given. Patient treated it with OTC pain meds.
Age: 80.0
Sex: M
Vaccine: FLU3, PPV, FLU4, PPV, FLU4
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Patient had extreme soreness in the arm where the Pneumovax was given. Patient treated it with OTC pain meds.
Age: 65.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Peripheral swelling
Clinical narrative: Left arm was swollen from armpit to hand and fingertips.
Age: 4.0
Sex: M
Vaccine: DTAP, FLUX, MMRV
Symptoms: Blood sodium decreased, Blood test, Decreased appetite, Diarrhoea, Injection site rash
Clinical narrative: Lethargy, vomiting, diarrhea, fever, loss of appetite, unusual rash at injection site measuring approx 8inches by 4 inch.  Symptoms have not resolved.
Age: 4.0
Sex: M
Vaccine: DTAP, FLUX, MMRV
Symptoms: Lethargy, Pyrexia, Vomiting
Clinical narrative: Lethargy, vomiting, diarrhea, fever, loss of appetite, unusual rash at injection site measuring approx 8inches by 4 inch.  Symptoms have not resolved.
Age: 5.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling of upper right arm.
Age: 12.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Swelling, redness, and warmth to upper right arm.
Age: 46.0
Sex: F
Vaccine: FLU4
Symptoms: Induration, Injection site pain, Injection site rash, Injection site swelling, Injection site urticaria
Clinical narrative: Wheal and raised rash at injection site. Significant pain at injection site, Hardened area palpated subdermal.
Age: 61.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness
Clinical narrative: Extreme dizziness.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Axillary pain, Blister, Erythema, Flank pain, Injection site erythema
Clinical narrative: Fever, pain and redness at injection site with 2 'mounds' of swelling that are very firm to the touch.  Slight itching.  By 10/16/2016, fever had elevated, swelling and pain was more severe with pain and swelling past the elbow to the forearm, the armpit, and down the left side.  Redness also continued with blister-like forms in swollen area.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site induration, Injection site pain, Injection site pruritus, Injection site swelling, Oedema peripheral
Clinical narrative: Fever, pain and redness at injection site with 2 'mounds' of swelling that are very firm to the touch.  Slight itching.  By 10/16/2016, fever had elevated, swelling and pain was more severe with pain and swelling past the elbow to the forearm, the armpit, and down the left side.  Redness also continued with blister-like forms in swollen area.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Fever, pain and redness at injection site with 2 'mounds' of swelling that are very firm to the touch.  Slight itching.  By 10/16/2016, fever had elevated, swelling and pain was more severe with pain and swelling past the elbow to the forearm, the armpit, and down the left side.  Redness also continued with blister-like forms in swollen area.
Age: 62.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: Zostavax was the vaccine administered. Itching after administration and next day swelling of arm with redness.
Age: 46.0
Sex: F
Vaccine: FLU4
Symptoms: Dermatitis acneiform, Insomnia, Malaise, Nasal congestion, Pruritus
Clinical narrative: Nasal congestion; rash on torso/back; itchiness on torso/back; malaise; difficulty falling asleep.
Age: 46.0
Sex: F
Vaccine: FLU4
Symptoms: Rash
Clinical narrative: Nasal congestion; rash on torso/back; itchiness on torso/back; malaise; difficulty falling asleep.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema
Clinical narrative: Solid red circle 3 to 4 inches across with injection mark in the center.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site irritation, Injection site pruritus, Injection site rash
Clinical narrative: Pt noticed a red bump in vaccination area sometime during the evening on 10/14/16.  She stated that overnight on 10/15/16 the red bump got larger and was a red, irritated area that covered from the vaccination area to mid upper arm in approximately a one-inch wide strip.  Patient stated it was itchy, but not really painful and denied any symptoms of swelling or shortness of breath.  Patient was instructed to take Benadryl and to go to the ER if she experienced swelling or shortness of breath or to seek medical attention if the area worsened or did not get better with benadryl after a day or two.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Hypersensitivity, Hypoaesthesia, Injection site erythema, Injection site pain, Lip swelling
Clinical narrative: PATIENT CAME TO PHARMACY ON 10/16/16 AT 11:15 AM STATED SWOLLEN LEFT CORNER OF LIP AND NUMBNESS STARTED TO OCCUR AT 10:30 AM THE SAME MORNING.  HAS SOME REDNESS AND SORENESS AT INJECTION SITE.  ADVISED PATIENT TO TAKE BENADRYL FOR ALLERGIC REACTION AND SEEK MEDICAL TREATMENT.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Burning sensation, Facial pain, Hypoaesthesia, Injection site erythema, Injection site inflammation
Clinical narrative: PATIENT CAME TO PHARMACY ON 10/16/16 AT 11:15 AM STATED SWOLLEN LEFT CORNER OF LIP AND NUMBNESS STARTED TO OCCUR AT 10:30 AM THE SAME MORNING.  HAS SOME REDNESS AND SORENESS AT INJECTION SITE.  ADVISED PATIENT TO TAKE BENADRYL FOR ALLERGIC REACTION AND SEEK MEDICAL TREATMENT.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Injection site swelling, Lip swelling, Swelling face
Clinical narrative: PATIENT CAME TO PHARMACY ON 10/16/16 AT 11:15 AM STATED SWOLLEN LEFT CORNER OF LIP AND NUMBNESS STARTED TO OCCUR AT 10:30 AM THE SAME MORNING.  HAS SOME REDNESS AND SORENESS AT INJECTION SITE.  ADVISED PATIENT TO TAKE BENADRYL FOR ALLERGIC REACTION AND SEEK MEDICAL TREATMENT.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Injection site swelling, Lip swelling, Mouth swelling, Swelling face
Clinical narrative: PATIENT CAME TO PHARMACY ON 10/16/16 AT 11:15 AM STATED SWOLLEN LEFT CORNER OF LIP AND NUMBNESS STARTED TO OCCUR AT 10:30 AM THE SAME MORNING.  HAS SOME REDNESS AND SORENESS AT INJECTION SITE.  ADVISED PATIENT TO TAKE BENADRYL FOR ALLERGIC REACTION AND SEEK MEDICAL TREATMENT.
Age: 30.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Pain, Pruritus, Skin warm
Clinical narrative: Redness at site of injection about 4 inches in diameter.  Warm to the touch and itchy. Painful to touch.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Headache, Herpes zoster, Pain, Pruritus
Clinical narrative: Shingles outbreak..redness, swelling, headache, pain, itching.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Swelling
Clinical narrative: Shingles outbreak..redness, swelling, headache, pain, itching.
Age: 71.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Red Rash on inner right arm running entire length of arm.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Abnormal faeces, Diarrhoea, Dyspepsia, Flatulence, Hypertension
Clinical narrative: High blood pressure, 12:00AM till 7:00 AM on 10/09/2016. Smelly, foul diarrhea several times on 10/10/2016 and 10/11/2016.  Both diarrhea and vomiting on 10/12/2016.  Slow recovery with diarrhea still ongoing on 10/13/2016 and 10/14/2016. Noticeable swelling and pain at injection site. Gas pains and indigestion 10/09/2016 through 10/14/2016.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling, Vomiting
Clinical narrative: High blood pressure, 12:00AM till 7:00 AM on 10/09/2016. Smelly, foul diarrhea several times on 10/10/2016 and 10/11/2016.  Both diarrhea and vomiting on 10/12/2016.  Slow recovery with diarrhea still ongoing on 10/13/2016 and 10/14/2016. Noticeable swelling and pain at injection site. Gas pains and indigestion 10/09/2016 through 10/14/2016.
Age: 61.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Bright red, swollen area warm to touch around injection area. About 2 1/2" in diameter. Lighter pink area, slightly swollen radiating from injection area about 5" from injection site to arm area above elbow.  Extremely itchy directly around injection site.
Age: 28.0
Sex: F
Vaccine: FLU4
Symptoms: Headache, Nausea, Pyrexia
Clinical narrative: Severe headache. Fever of 101.6. Nausea.
Age: 63.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Rash macular
Clinical narrative: Patient's husband said her arm, down to her elbow was swollen, red and painful when he called late 10/15/2016. Said was not getting any better.  Recommened benadryl and ice (15 min on and 45 off).  Told if got worse go to urgent care.  Called patient Sunday at 10:00am, she said it was much better, swelling almost gone and red/pink splotchiness gone.  She had taken benadryl and iced last night and this morning.  I told her if it got any worse to seek medical attention.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Facial paralysis, Neuralgia, Nuclear magnetic resonance imaging brain abnormal
Clinical narrative: Bell's palsy left--pain in left trigeminal distribution, facial droop, seen in ER by neurology, diagnosed with Bell's palsy. Treated with prednisone and VALTREX. Facial droop has not yet resolved.
Age: 79.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Patient returned to the pharmacy the following day from receiving vaccination.  The immunized arm was swollen, red, warm to touch from shoulder down to elbow.  After notifying PCP, patient was directed to have it looked at that afternoon.
Age: 58.0
Sex: M
Vaccine: FLUX
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Initial pain at injection location stopped on this day, but later in the evening, I began experiencing INTENSE pain in the shoulder/collarbone region on the side of the injection. Could barely lift arm, could not lay or stand comfortably. Pain has lessened slightly, but increases throughout the day. Still suffering pain on 10/16/2016 PM.
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Death, Respiratory arrest, Resuscitation
Clinical narrative: Child was sleeping in mother's arms sometime in the evening and noticed child was not breathing and immediately began CPR and called 911. Code called at hospital @1943pm. ONSET TIME ESTIMATED as I will not contact parents for this.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Blood glucose normal, Computerised tomogram normal, Electroencephalogram normal, Generalised tonic-clonic seizure, Laboratory test normal
Clinical narrative: Grand mal seizure. Taken to ED, evaluation including CT, MRI brain, chemistries all normal, o/n EEG negative. Undergoing further neurology evaluation.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Nuclear magnetic resonance imaging brain normal, White blood cell count normal
Clinical narrative: Grand mal seizure. Taken to ED, evaluation including CT, MRI brain, chemistries all normal, o/n EEG negative. Undergoing further neurology evaluation.
Age: 11.0
Sex: M
Vaccine: HPV9
Symptoms: Activities of daily living impaired, Pain, Skin papilloma
Clinical narrative: A single large wart came up on each of his index fingers. They are very sore and are located at the first knuckle on each finger. I took him back to the Dr. on Oct. 3 to have them treated. It is hard for him to play basketball, and hold his pencil to write in class.
Age: 20.0
Sex: F
Vaccine: FLUX
Symptoms: Back pain, Injection site erythema, Neck pain, Pyrexia, Renal pain
Clinical narrative: Emense pain starting the from top of neck all the way to lower back on the side of injection. Felt a lot of pain on both sides where kidneys are located. On 10/15/2016 at 9:00am there was a red cicle 2 inches in diameter around injection site. Pain continued and spread to other side of body. By 5:00PM on 10/16/2016 pain continued, neck was stiff and began to run a low fever of 99.3.
Age: 61.0
Sex: F
Vaccine: FLU4, TDAP, VARZOS
Symptoms: Asthenia, Chills, Erythema, Fatigue, Oropharyngeal pain
Clinical narrative: Onset was extremely sore throat, low fever (no thermometer available), chills, weakness and soreness throughout body, extreme fatigue. I received three vaccines: Zoster, Tetanus and flu. Strange red mark on back of upper right arm. Just barely feeling better today.
Age: 61.0
Sex: F
Vaccine: FLU4, TDAP, VARZOS
Symptoms: Pain, Pyrexia
Clinical narrative: Onset was extremely sore throat, low fever (no thermometer available), chills, weakness and soreness throughout body, extreme fatigue. I received three vaccines: Zoster, Tetanus and flu. Strange red mark on back of upper right arm. Just barely feeling better today.
Sex: F
Vaccine: FLUX, PPV
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist regarding a female patient of unknown age. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On an unspecified date, the patient received PNEUMOVAX 23 (lot#, expiry date and dosing details were not known) "every year with her influenza virus vaccine (unspecified)". No adverse effect was reported. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Pt noticed itching and redness at injection site 10/16/16 - right arm where ZOSTAVAX was administered.
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Redness, swelling and heat at the site of injection about 4x5 inches.
Age: 78.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Redness at site, heat at site - left arm only.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Pt. received FLUZONE HD on 10-13. Pt. came into pharmacy and stated she developed welts on her back and shoulders. Pt. following up with Dermatologist.
Age: 43.0
Sex: F
Vaccine: FLU4
Symptoms: Feeling abnormal, Throat tightness
Clinical narrative: Patient described driving to meet a friend after leaving pharmacy. She felt strange and closing of throat. She was close to hospital. Went to ER. They administered IV steroid and antihistamines.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician and from a support services director refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 23-JUL-2015, the patient was vaccinated with an improperly stored dose of VAQTA 25U/0.5 ml injection (lot # K005323, expiry date 10-FEB-2017; dose and route of administration were not reported). There were no concomitant therapies reported. The dose of the vaccine was exposed to a temperature excursion (date unspecified), lasting for 48 hours, with the lowest recorded temperature of 32 degrees Fahrenheit (0 degree Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.